Black Rock Inc. Ptc Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,772,140 shares of PTCT stock, worth $352 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,772,140
Previous 7,565,086
2.74%
Holding current value
$352 Million
Previous $220 Million
8.0%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PTCT
# of Institutions
307Shares Held
80.1MCall Options Held
255KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA8.85MShares$401 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$351 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$214 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$213 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.18MShares$144 Million0.08% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.24B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...